01.
Details
Strength:10mg
Form:Lyophilized research material
Testing:Third-party tested
Documentation:COA available
PT-141 — bremelanotide, a melanocortin receptor agonist — studied in central signaling pathways.
PT-141 (bremelanotide) is a lab-made 7-amino-acid peptide. It was developed out of a bigger molecule called Melanotan II. Palatin Technologies brought it through the FDA, and it was approved in 2019 as Vyleesi for women with low sexual desire. Unlike Viagra-type drugs that work on blood flow, PT-141 works in the brain.
Keep lyophilized research material sealed, protected from light, and handled with standard laboratory controls. Follow internal SOPs for storage, reconstitution, labeling and disposal.
Approved (2019, for premenopausal HSDD in women, brand name Vyleesi)
PT-141 is bremelanotide, a cyclic melanocortin receptor agonist derived from Melanotan II research. PubChem indexes bremelanotide at CID 9941379 with formula C50H68N14O10 and molecular weight 1025.2 g/mol.
We display batch-level certificates of analysis (mass spec, HPLC purity) for all research-grade material.
Lyophilized peptides manufactured in GMP-certified facilities. No fillers, no shortcuts.
We display batch-level certificates of analysis (mass spec, HPLC purity) for all research-grade material.
Discreet, temperature-controlled shipping included on every order. No hidden fees.
Orders processed within 24 hours. Most shipments arrive in 3–5 business days.
IMPORTANT: All products sold by Premium Peptides are intended for laboratory research only. They are not intended for human consumption, medical use, or as substitutes for prescription medications. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.